• SENSEX
    NIFTY 50
Healthcare

USFDA inspection at Aurobindo Pharma's Unit IV still open and under review

Updated : February 22, 2020 12:36 PM IST

USFDA has also rescinded the Voluntary Action Initiated (VAl) status given to the facility, it said.
The drug regulator conducted inspection at Unit IV from November 4, 2019 to November 13, 2019.

You May Also Like

Live TV
Advertisement